April 7 (Reuters) - Aerovate Therapeutics Inc AVTE.O:
AEROVATE THERAPEUTICS ANNOUNCES RANGE OF EXPECTED CASH DIVIDEND IN CONNECTION WITH THE PROPOSED MERGER WITH JADE BIOSCIENCES
AEROVATE THERAPEUTICS INC - CASH DIVIDEND EXPECTED TO BE IN RANGE OF $67.6 - 69.6 MILLION
Source text: ID:nPn9bbfTsa
Further company coverage: AVTE.O
((Reuters.Briefs@thomsonreuters.com;))